表紙
年間契約型資訊服務

世界非專利藥品市場

World Generic Markets

出版商 Fitch Solutions, Inc. 商品編碼 12843
出版日期 12 Issues/Year 內容資訊 英文 20 Pages
價格
Back to Top
世界非專利藥品市場 World Generic Markets
出版日期: 12 Issues/Year 內容資訊: 英文 20 Pages
簡介
World Generic Markets

World Generic Markets (WGM)協助忙碌的管理者掌握最新 的全球非專利藥品市場上的動態。

近年來,非專利藥品市場的轉變 造成許多專利藥品獲利甚佳,在藥界佔據一席之地。不僅如此,進階的製造廠也 積極開發新市場,同時為研究藥品及非專利藥品製造者開啟新機會。在健康醫療付款人與政府 嚴格審核藥品花費之下,是接觸全球非專利藥品的時候了。

WGM排除萬難,致力為您提供:

  • 製造廠
  • 商品
  • 聯盟計畫
  • 專利/訴訟
  • 價格/補償金
  • 政府政策 
目錄
Product Code: 1475-0856

BMI View: This FY13 report shows that final settlement agreements are on an upward trend, but those with potential pay-for-delay implications are currently falling. The report acts as an annual barometer for current legal thinking on the issue; the lack of a clear trend reflects fluctuating legal opinions. The FY14 report will show more fully the impact of the Supreme Court ruling in 2013 on pay-for-delay agreements.

Table of Contents

Editor's Note

  • Despite Overall Upward Trend, FTC Report Shows Fluctuations In Settlement Agreements

Americas

Chile

  • Company News
    • Abbott Completes Acquisition Of CFR

USA

  • Company News
    • Fosun To Invest In Amerigen
    • Actavis Launches US Generic Speciality Injectable Portfolio
  • Patent & Litigation News
    • Helsinn Reaches Palonosetron Settlement With Sandoz
    • Sunovion Files Lurasidone Patent Infringement Lawsuits
    • Actavis Challenges US Abstral Patents
    • Akorn Initiates Difluprednate Patent Challenge
    • Mounting Patent Challenges Will Determine Supernus' Financial Rewards
  • Product Updates
    • Mylan Launches Valsartan In US
    • US Approval Of Sandoz' Filgrastim Advances With Small Steps, Not Giant Leaps
    • Colchicine Marketing Battle To Re-Emerge In US
    • Perrigo Launches Testosterone Gel In US
    • Hospira Files US Epoetin Alfa Biosimilar Application
    • Perrigo Launches Clobetasol Spray In US
    • Jubilant Gains US Mycophenolate And Rizatriptan Approvals
    • Mylan Launches Lamivudine In US
    • Elite Commences Isradipine Shipments
    • Akorn Gains US Phenylephrine Ophthalmic Solution Approval

Europe

UK

  • Regulatory News
    • NICE Updates Biosimilars Guidance

Asia/Pacific

India

  • Patent & Litigation News
    • Gilead Likely To Weather The Indian Sofosbuvir Patent Rejection Storm

Singapore

  • Company News
    • Strides' Singapore Subsidiary Gains International Headquarters Status
Back to Top